ALPP CAR-T
Cell therapyexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2018 (NCT06556108)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Alkaline phosphatase placental-likeImmunity, passive
ALPG immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07123493 | Early Phase 1 (Phase 1) | Aug 28, 2025 | Government of China |
| NCT07108140 | Early Phase 1 (Phase 1) | May 20, 2025 | Jinlin University, TCRCure Biopharma Corp. |
| NCT04627740 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2020 | People's Liberation Army of China, TCRCure Biopharma Corp. |
| NCT06556108 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2018 | People's Liberation Army of China |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| People's Liberation Army of China | Government | 2 | 2 | 1 | 2018 |
| TCRCure Biopharma Corp. | For profit | 2 | 1 | 2 | 2020 |
| Government of China | Government | 1 | 1 | 1 | 2025 |
| Jinlin University | Academic/Hospital | 1 | 0 | 1 | 2025 |
4 organizations
Page 1 / 1